Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Imbria Pharmaceuticals, Inc.

Clinical trials sponsored by Imbria Pharmaceuticals, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug aims to ease symptoms of stiff heart muscle Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1

Heart drug trial pulled before it even started

Symptom relief Cancelled

This was a planned Phase 2 study to test whether the drug IMB-1018972 could safely help people with refractory angina—chest pain that doesn't improve with standard treatments. The study aimed to measure exercise capacity, angina symptoms, and activity levels. However, the trial w…

Phase 2 • Sponsor: Imbria Pharmaceuticals, Inc. • Aim: Symptom relief

Last updated Jun 27, 2026 07:56 UTC